Eukarya PharmaSite /ID# 265274

Monterrey, Nuevo León 64718

1 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis — Recruiting now